ARES
Next earnings: Jul 30, 2026 · Before open
Signal
Mixed11
Price
1
Move+2.51%Positive session
Volume
1
Volume0.1× avgLight volume
Technical
1
RSIRSI 45Momentum negative
PRICE
Prev Close
123.15
Open
123.56
Day Range121.90 – 127.74
121.90
127.74
52W Range95.80 – 195.26
95.80
195.26
31% of range
VOLUME & SIZE
Avg Volume
3.1M
FUNDAMENTALS
P/E Ratio
71.9x
Premium valuation
EPS (TTM)
Div Yield
0.03%
Beta
1.56
High vol
Performance
1D
+0.73%
5D
+3.13%
1M
+21.15%
3M
-5.06%
6M
-19.51%
YTD
-23.37%
1Y
-23.58%
Best: 1M (+21.15%)Worst: 1Y (-23.58%)
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +48% YoY · 71% gross margin
Valuation
EXPENSIVE
P/E 72x vs ~20x sector
Health
WEAK
CR 0.8 (low) · FCF $6.89/sh
Neutral
Key MetricsTTM
Market Cap$62.17B
Revenue TTM$6.31B
Net Income TTM$622.78M
Free Cash Flow-$37.02M
Gross Margin70.7%
Net Margin9.9%
Operating Margin22.9%
Return on Equity14.2%
Return on Assets2.2%
Debt / Equity3.49
Current Ratio2.24
EPS TTM$2.78
Alpha SignalsFull Analysis →
What Moves This Stock

Quarterly fundraising and net inflows - ability to raise new committed capital across strategies

Fee-related earnings growth and margin expansion - core profitability metric excluding volatile performance fees

Realization activity and carry conversion - exits that crystallize performance fees (e.g., PE fund distributions)

Credit portfolio performance - particularly direct lending default rates and non-accruals given $180B+ credit AUM

Macro Sensitivity
Economic Cycle

high - Private equity exit activity and M&A volumes collapse in recessions, delaying performance fee realization. Direct lending origination volumes correlate with middle-market M&A and corporate financing activity. Real estate valuations and transaction volumes are highly cyclical. However, permanent capital vehicles and long-duration funds (10-12 year life) provide some insulation from short-term volatility.

Interest Rates

Rising rates have mixed impact: (1) Positive for direct lending yields - floating rate loans (95%+ of credit book) reprice higher, expanding spreads and portfolio yields from 10% to 11-12% range. (2) Negative for fundraising - higher risk-free rates compress private market return premiums, making 12-15% net IRR targets harder to achieve. (3) Negative for valuations - alternative asset managers trade at 15-25x P/E; rising rates compress multiples as yield alternatives become attractive. (4) Negative for portfolio companies - higher debt service costs stress leveraged buyouts.

Key Risks

Fee compression from passive alternatives and interval funds - retail-oriented products face pricing pressure versus traditional private funds charging 1.5% + 20% carry

Regulatory scrutiny of private credit - potential capital requirements or lending restrictions if regulators view direct lenders as systemically important non-bank financiers

Denominator effect - institutional LPs hitting private asset allocation limits may reduce commitments to new funds if public equity values decline

Investor Profile

growth - Investors seek 15-20% annual earnings growth from AUM compounding, margin expansion, and alternative asset secular tailwinds. The stock attracts long-duration growth investors willing to tolerate performance fee volatility and valuation compression during rate hikes. Recent 27% one-year decline reflects multiple compression from 25x to 18x P/E as rates rose.

Watch on Earnings
High-yield credit spreads (BAMLH0A0HYM2) - leading indicator of credit stress and direct lending portfolio performanceMiddle-market M&A volumes - drives direct lending origination and PE exit activityLeveraged loan default rates - proxy for credit quality in Ares' $180B+ direct lending book10-year Treasury yield (GS10) - affects valuation multiples and fundraising environment
Health Radar
1 strong1 watch4 concern
36/100
Liquidity
0.78Concern
Leverage
0.18Strong
Coverage
1.9xConcern
ROE
14.5%Watch
ROIC
4.2%Concern
Cash
$1.5BConcern
ANALYST COVERAGE21 analysts
BUY
+29.9%upside to target
L $140.00
Med $164.00consensus
H $215.00
Strong Buy
15%
Buy
1571%
Hold
524%
16 Buy (76%)5 Hold (24%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
5/10
Technicals
RSI RangeRSI 45 — Bearish momentum
Volume
Volume FlowLean Accumulation
Fundamentals
Last EarningsMissed estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 0.78 — liquidity risk
Upcoming Events
EEarnings ReportMay 9, 2026
Tomorrow
DEx-Dividend DateAug 6, 2026
In 90 days
PDividend PaymentSep 7, 2026
In 122 days
Technicals
Technical SetupBEARISH
Technicals →

Trend

DowntrendDeath Cross · 50D trails 200D by 2.9%

-10.8% vs SMA 50 · -13.3% vs SMA 200

Momentum

RSI45.5
Neutral territory
MACD-5.28
Below zero — bearish pulse · expanding
Market Position
Price Levels
52W High
$195.3+54.7%
EMA 200
$145.5+15.2%
EMA 50
$135.4+7.3%
Current
$126.2
52W Low
$95.80-24.1%
52-Week RangeMid-range
$95.8031th %ile$195.3
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:6
Dist days:2
Edge:+4 acc
Volume Context
Avg Vol (50D)1.5M
Recent Vol (5D)
1.3M-14%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 12 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$3.5B
$3.4B$3.6B
$4.04
±3%
High11
FY2025
$4.6B
$4.4B$4.7B
+31.0%$5.00+23.7%
±4%
High12
FY2026(current)
$5.7B
$5.5B$6.0B
+24.9%$6.03+20.7%
±6%
High9
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryARES
Last 8Q
-1.5%avg beat
Beat 4 of 8 quartersMissed 4 Estimates rising
+1%
Q3'24
+1%
Q4'24
-9%
Q1'25
+16%
Q2'25
-5%
Q3'25
+3%
Q4'25
-14%
Q1'26
-6%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →
No recent activity
Deutsche BankHold → Buy
Feb 6
UPGRADE
OppenheimerPerform → Outperform
Oct 14
UPGRADE
OppenheimerOutperform → Perform
May 15
DOWNGRADE
OppenheimerOutperform
Apr 16
UPGRADE
Deutsche BankBuy → Hold
Jun 13
DOWNGRADE
BMO CapitalOutperform → Market Perform
Nov 14
DOWNGRADE
Insider Activity
SEC Filings →
2 Buys/4 SellsNet Selling
Olian Judy D.Dir
$60K
Feb 20
BUY
Bhutani AshishDir
$1.3M
Feb 6
BUY
Sagati Aghili NaseemGeneral Counsel
$38K
Feb 4
SELL
Sagati Aghili NaseemGeneral Counsel
$39K
Feb 4
SELL
Sagati Aghili NaseemGeneral Counsel
$13K
Feb 4
SELL
Sagati Aghili NaseemGeneral Counsel
$40K
Feb 4
SELL
Financials
Dividends3.72% yield
+23.7% avg annual growth
Annual Yield3.72%
Quarterly Div.$1.3500
Est. Annual / Share$5.40
FrequencyQuarterly
Q3'24
Q4'24
Q1'25
Q2'25
Q3'25
Q4'25
Q1'26
Q2'26

Dividend per payment — last 8 periods

INSTITUTIONAL OWNERSHIP

1
PRINCIPAL FINANCIAL GROUP INC
4.0M
2
Nuveen, LLC
2.4M
3
LRI Investments, LLC
2.3M
4
Curated Wealth Partners LLC
1.5M
5
UBS Group AG
1.4M
6
Bank of New York Mellon Corp
1.1M
7
Hamlin Capital Management, LLC
945K
8
ENVESTNET ASSET MANAGEMENT INC
920K
News & Activity

ARES News

20 articles · 4h ago

About

ares management, l.p. is a publicly traded, leading global alternative asset manager with approximately $106 billion of assets under management,* and more than 15 offices in the united states, europe, asia and australia.* since its inception in 1997, ares has adhered to a disciplined investment philosophy that focuses on delivering strong risk-adjusted investment returns throughout market cycles. ares believes each of its distinct but complementary investment groups in credit, private equity and real estate is a market leader based on assets under management and investment performance. ares was built upon the fundamental principle that each group benefits from being part of the greater whole. for more information, please visit www.aresmgmt.com. * as of december 31, 2017, aum amounts include funds managed by ivy hill asset management, l.p., a wholly owned portfolio company of ares capital corporation and a registered investment adviser.

CEO
Michael Arougheti
Michelle ArmstrongMD & President of the Ares Charitable Foundation
Blair Victor JacobsonPartner & Co-President
Cameron DewarDirector & Co-President of Ares
PeersFinancial Services(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
ARES
$126.25+0.73%$40.4B44.3+6655.1%815.1%1492
$302.17-2.74%$834.5B14.5+330.7%2039.3%1505
$318.75+0.78%$617.3B27.6+1134.0%5014.5%1499
$495.72+1.84%$440.0B28.7+1641.6%4564.7%1489
$51.29-1.59%$377.0B12.1-45.1%1592.6%1503
$193.07-1.64%$300.4B16.4+1147.7%1466.4%1519
$936.53-1.22%$272.7B15.6-138.4%1373.0%1517
Sector avg-0.55%22.7+1532.2%2409.4%1503